Received Mar 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Fever; Tiredness; Muscle pain; This non-serious case was reported by a nurse via call center representative and described the occurrence of fever in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced fever (Verbatim: Fever), tiredness (Verbatim: Tiredness) and muscle pain (Verbatim: Muscle pain). The outcome of the fever, tiredness and muscle pain were unknown. It was unknown if the reporter considered the fever, tiredness and muscle pain to be related to Shingrix. It was unknown if the company considered the fever, tiredness and muscle pain to be related to Shingrix. Additional Information: GSK Receipt Date: 12-FEB-2025 The registered nurse mentioned during the call as an example that his mother felt muscle pain, tiredness and fever after receiving Shingrix, and that 95% of their patients are usually feeling similar symptoms after a Shingrix dose. The reporter did not have lot number for the vaccine and refused to provide any additional details about this case.; Sender's Comments: US-GSK-US2025018347:same reporter